Rgenta Therapeutics Presents Preclinical Data from RGT-61159
12 Jun 2025 //
GLOBENEWSWIRE
Rgenta Therapeutics Presents Data on RSwitch Technology
13 May 2025 //
PR NEWSWIRE
Rgenta Announces First Patients Dosed In Ph1a/b in Adenoid Carcinoma
08 Oct 2024 //
PR NEWSWIRE
FDA Clears Rgenta`s IND For RGT-61159 In ACC And Colorectal Cancer
10 Jul 2024 //
PR NEWSWIRE
Rgenta Presents RGT-61159 Preclinical Data At ASCO 2024
31 May 2024 //
PR NEWSWIRE